Srihaas Lifesciences

Hyderabad, India Founded: 2018 • Age: 8 yrs
Manufactures and supplies pharmaceutical intermediates and specialty chemicals.

About Srihaas Lifesciences

Srihaas Lifesciences is a Healthcare company based in Hyderabad (India) founded in 2018. It manufactures and supplies pharmaceutical intermediates and specialty chemicals. It operates on a B2B model. The company has 15 employees. Its Indian entity Sri Haas Life Sciences Private Limited reported revenue of β‚Ή28.99 Cr. Its focus areas include Pharmaceuticals, Manufacturing and API Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Srihaas Lifesciences, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api intermediates. Manufactures and supplies pharmaceutical intermediates and specialty chemicals. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹28.99 Cr

    FY 2025 · +60% YoY

  • Net Profit
    ₹4.32 Cr

    FY 2025 · 15% margin

  • EBITDA
    ₹7.28 Cr

    FY 2025 · 25% margin

  • Employee Count
    15

Board of directors of Sri Haas Life Sciences Private Limited (Srihaas Lifesciences)

Sri Haas Life Sciences Private Limited is the primary company behind Srihaas Lifesciences. The board of Sri Haas Life Sciences Private Limited currently have 2 directors; the longest-serving is Mudunuru Raju Sasikumar, appointed in 2018. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mudunuru Raju Sasikumar
DIN 03059826
Managing Director12 Jun 20188 yrs 5 moSri Haas Life Sciences Private Limited
Devi Vasundara Kutcherlapati
DIN 08803803
Director23 Jul 20206 yrs 3 moSri Haas Life Sciences Private Limited

Financials of Srihaas Lifesciences

Figures of Sri Haas Life Sciences Private Limited, the primary company behind Srihaas Lifesciences, for FY 2025. Revenue was ₹28.99 Cr (+60% year on year). Net profit was ₹4.32 Cr (15% margin). EBITDA was ₹7.28 Cr (25% margin). Revenue has grown at a compounded annual rate of +8% over three years and +32% over five years.

  • ₹28.99 CrRevenue · FY 2025 · +60% YoY
  • ₹4.32 CrNet profit · 15% margin
  • ₹7.28 CrEBITDA · 25% margin
  • ₹34 LakhPaid-up capital
  • 15Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +32%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sri Haas Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Srihaas Lifesciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Srihaas Lifesciences

Srihaas Lifesciences has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Srihaas Lifesciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Srihaas Lifesciences

Srihaas Lifesciences was founded in 2018.

Srihaas Lifesciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Srihaas Lifesciences has 15 employees.

The primary company behind Srihaas Lifesciences, Sri Haas Life Sciences Private Limited, reported revenue of β‚Ή28.99 Cr for FY 2025, up 60% year on year.

Srihaas Lifesciences, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api intermediates. Manufactures and supplies pharmaceutical intermediates and specialty chemicals. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Srihaas Lifesciences's top competitors include Laurus Labs, Symbiotec and SeQuent.

Srihaas Lifesciences operates through Sri Haas Life Sciences Private Limited.

The legal entities of Srihaas Lifesciences currently have 2 directors, including Mudunuru Raju Sasikumar, Devi Vasundara Kutcherlapati.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available